Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Lorlatinib is a third-generation anaplastic lymphoma kinase (ALK)/c-ros oncogene···【more】
Release date：2026-01-23Recommended：9
Lorlatinib is a third-generation dual-target inhibitor of ALK/ROS1, primarily in···【more】
Release date：2026-01-23Recommended：10
The price of lorlatinib varies significantly, mainly depending on the drug sourc···【more】
Release date：2026-01-23Recommended：9
This drug is a prescription medicine. Its use must strictly follow the doctor’s ···【more】
Release date：2026-01-23Recommended：9
The price of Lorlatinib is subject to significant fluctuations due to the impact···【more】
Release date：2026-01-23Recommended：9
The monthly treatment cost of lorlatinib currently available in China fluctuates···【more】
Release date：2026-01-23Recommended：11
Pfizer recently announced that the U.S. Food and Drug Administration (FDA) has a···【more】
Release date：2026-01-23Recommended：11
On March 3, 2021, Pfizer announced that the U.S. Food and Drug Administration (F···【more】
Release date：2026-01-23Recommended：14
At the Presidential Symposium of the 2020 ESMO Annual Congress, results of a hea···【more】
Release date：2026-01-23Recommended：9
In December 2020, the U.S. Food and Drug Administration (FDA) accepted a supplem···【more】
Release date：2026-01-23Recommended：11
Pfizer recently announced that the Phase III CROWN study, which evaluates Lorbre···【more】
Release date：2026-01-23Recommended：13
Lorbrena (generic name: Lorlatinib) is a next-generation tyrosine kinase inhibit···【more】
Release date：2026-01-23Recommended：10
